Effects of Delta-9-THC and Iomazenil in Healthy Humans

Conditions

Mental Disorders | Psychotic Disorders | Schizophrenia

What is the purpose of this trial?

The study aims to examine the combined effects of delta-9-tetrahydrocannabinol (∆-9-THC or THC) and iomazenil on thinking, perception, mood, memory, attention, and electrical activity of the brain (EEG). THC is the active ingredient of marijuana, cannabis, "ganja", or "pot". Iomazenil is a drug that works opposite to drugs like valium. The purpose of this study is to determine whether the administration of iomazenil will alter the effects of THC.



Participation Guidelines

Age:
18 Years - 55 Years
Gender:
Male

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
February 2009
Last Updated:
June 13, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00982982